Stocks and Investing Stocks and Investing
Wed, November 4, 2020

David Lewis Maintained (AVNS) at Sell with Increased Target to $36 on, Nov 4th, 2020


Published on 2024-10-27 14:38:10 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Avanos Medical, Inc." (AVNS) at Sell with Increased Target from $31 to $36 on, Nov 4th, 2020.

David, nor any peers, have made any analyst calls on AVNS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources